Novel Therapeutic Agents and Innovative Treatment Strategies Against Infectious Diseases
A special issue of Future Pharmacology (ISSN 2673-9879).
Deadline for manuscript submissions: 30 September 2025
Special Issue Editor
Interests: drug delivery; medicinal chemistry; drug discovery and development; antimycobacterial agents; antiviral agents; tuberculosis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue focuses on innovative therapeutics to combat infectious diseases, with particular attention to resistant and emerging pathogens. The rise of multi-drug-resistant (MDR) and extensively drug-resistant (XDR) strains has intensified the need for novel therapies across a broad spectrum of infectious diseases. We aim to spotlight advancements in the discovery of new therapeutic agents, including small molecules, biologics, and vaccines, alongside innovative drug delivery systems such as nanocarriers, lipid-based formulations, and targeted delivery strategies.
This Special Issue encompasses all microbial infections and places a particular emphasis on tuberculosis (TB), highlighting novel molecular targets and host-targeted therapies to circumvent microbial resistance and improve therapeutic outcomes. It also explores new pathways in infectious disease pathogenesis—such as amino acid biosynthesis, host–microbe interactions, and viral replication processes—as potential innovative targets for drug discovery.
We invite original research articles and reviews that advance the understanding and treatment of microbial infections by integrating insights from pharmacology and molecular biology. We also welcome contributions that investigate innovative therapeutic approaches, new drug targets, mechanisms of action, and delivery systems that address the pressing global health challenges posed by infectious diseases and antimicrobial drug resistance.
Dr. Sara Consalvi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Future Pharmacology is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- medicinal chemistry
- tuberculosis
- TB drug discovery and development
- host-targeted therapies
- antibacterials
- antivirals
- antimicrobials
- drug resistance
- drug delivery
- drug candidate
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
